Posted on

“It’s been 50 years since the war and I finally came home”

GoDaddy Billionaire Bob Parsons Believes Psychedelics Can Heal Trauma—And He’s Putting His Money (And Brain) On The Line

Bob Parsons, founder of GoDaddy, suffered from PTSD after witnessing “grisly combat” in the Vietnam War. 

It wasn’t until he went through a multiday therapy treatment with psilocybin, ayahuasca, and LSD that he began to feel like his old self again. 

“What I think psychedelics did was a reset. Now, I’m like people who haven’t been in combat to a certain degree,” he believes. 

Bob is on a mission to help other veterans battling PTSD. He donated $5M to Mount Sinai’s psychedelic research center to fund MDMA therapy training for healthcare practitioners. 

PDF of article

Posted on

MDMA treatment helped save my life

“MDMA Treatment Helped Save My Life”

“I am a completely different person then versus now. My PTSD will always live inside of me, but it’s no longer taking over my life,” says Sarah, one of the participants in MAPS’ MDMA trial.

Sarah endured a traumatic sexual assault that gave her painful flashbacks. 

Over three MDMA therapy sessions, she was able to go back to the experience and fill in the gaps in her memory to fully process what had happened in a safe environment. In the final session, she confronted her attacker and was able to find forgiveness for them. 

“I felt like I was given freedom from the trauma,” she explains.

PDF of article

Posted on

Microdosing concert for group healing

Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands

On Saturday, Red Light Holland (TRIP) sponsored a first-of-its-kind microdosing concert to determine best practices for group microdosing services.

Participants attended a preparation session and received a customized dose of psilocybin from a therapist.

They spent the next three hours laying on the ground listening to a live classical music concert before attending an optional integration session.

“Both music and community have healing and connective qualities and we are excited to test the potential benefits of combining microdosing psilocybin truffles in this ground-breaking setting,” says one of the event organizers

Data from the event will be used to guide microdosing regulations Oregon and Washington.

PDF of article

Posted on

Numinus acquires Novamind

Numinus Wellness (NUMI) is acquiring Novamind (NM) for C$26.2M or $0.44 per share, a 51% premium on Novamind’s 20-day average. 

The combined company will run 13 wellness clinics and 4 psychedelic research sites focused on depression, anxiety, PTSD, and addiction.

Here’s some more info on the transaction:

PDF of article

Posted on

30% less opioid use

Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample

A recent survey of 200,000+ people found that those who have used psilocybin at least once are 30% less likely to have opioid use disorder. However, LSD, mescaline, and peyote use did not seem to have an impact on opioid use. Addiction is linked with abnormal serotonin neurotransmission. Since psilocybin targets the serotonin system, it may help protect against opioid addiction.

Learn more with Chloe Deutscher on TikTok

PDF of article

Posted on

MAPS celebrates bday with 30,000 doses of MDMA

MAPS Places Fully Validated, Multi-Kilogram Synthesis of MDMA in the Public Domain

MAPS developed the first validated method of synthesizing MDMA on an industrial scale while meeting Good Manufacturing Practices. And better yet, they are placing the process in the public domain to promote scientific advances and patient access. 

The 4-step process produces up to 5 kg of MDMA (or roughly 30,000 doses) with 99.9% purity.

With MDMA expected to be FDA-approved next year, this advancement comes at the perfect time to meet the growing demand for the drug 👏

Today is MAPS’ 36th birthday 🥳 See all that they’ve accomplished here.

Multidisciplinary Association for Psychedelic Studies – MAPS

PDF of article

Posted on

The most intense psychedelic could be perfect for new moms

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

Field Trip Health (FTRP) was granted a US patent for its formulation of 4-HO-DiPT (aka Isoprocin Glutarate), an extremely intense psychedelic lasting 2-3 hours. 

Field Trip will begin a Phase I safety trial within 3 months with hopes that it will lead to Phase II trials on treatment-resistant depression and postpartum depression.

Field Trip Health Logo

PDF of article

Posted on

New mushroom species + psilocybin for cows 🐄

New species of psychedelic mushroom believed to live in Kakadu National Park

We’d love to hear what PETA thinks of this idea…

Alistair McTaggart, a University of Queensland researcher, discovered what he believes is a new species of psychedelic mushroom in one of Australia’s biggest national parks.

When interviewed on the finding, he brought attention to an “under-explored” use of psilocybin: animal welfare. 

“Psilocybin has use in [treating] anxiety in humans, we don’t understand the effects of psilocybin on animals very well, but I think of slaughterhouses and what this could mean for the meat [processing] industry,” McTaggart explains. 

Who knows, maybe we’ll start seeing beef advertised as “shroom-fed” 🤷‍♀️

PDF of article